"How A Supercomputer Named Dr. Crusher Perfected Cancer Treatments For 21 Patients" - Arlene Weintraub
Samir Parekh, MBBS, associate professor of oncological sciences, medicine, hematology and medical oncology and director of translational research in myeloma at the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai, and his colleagues wanted to change the treatment paradigm in multiple myeloma. So they developed a system that uses artificial intelligence to match up multiple myeloma patients with drugs that are already on the market to treat other cancers. They tried the resulting recommendations in a group of 21 patients with treatment-resistant multiple myeloma and got positive results in all but five – a response rate that’s so high Dr. Parekh believes the idea could be extended to many other cancers. “The response was quite amazing, considering this was a challenging population that had pretty much failed every treatment out there,” said Dr. Parekh. The study was published in the journal JCO Precision Oncology.
- Samir Parekh, MBBS, Associate Professor, Oncological Sciences, Medicine, Hematology and Medical Oncology, Director, Translational Research in Myeloma, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Additional coverage: